Compile Data Set for Download or QSAR
maximum 50k data
Found 32 Enz. Inhib. hit(s) with all data for entry = 6063
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM47085(US8592454, 71b)
Affinity DataIC50:  0.0270nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50:  0.0290nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50:  0.0300nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50:  0.0310nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50:  0.0320nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50:  0.0390nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50:  0.0490nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106981(US8592454, 308)
Affinity DataIC50:  0.0700nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106977(US8592454, 104)
Affinity DataIC50:  0.0730nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50:  0.0750nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106973(US8592454, 4)
Affinity DataIC50:  0.110nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50:  2nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106981(US8592454, 308)
Affinity DataIC50:  2.40nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM47085(US8592454, 71b)
Affinity DataIC50:  7.10nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50:  7.10nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50:  12nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50:  42nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50:  59nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50:  77nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106975(US8592454, 61)
Affinity DataIC50:  99nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106977(US8592454, 104)
Affinity DataIC50:  100nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106975(US8592454, 61)
Affinity DataIC50: >100nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50:  120nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50:  120nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50:  140nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106975(US8592454, 61)
Affinity DataIC50:  290nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50:  600nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50:  650nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50:  1.10E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50:  1.40E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106973(US8592454, 4)
Affinity DataIC50:  4.20E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50:  4.40E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent